TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21771185

Group type: EXPERIMENTAL
Intervention: F‐File with NaOCl
Number of subjects: 48

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 48

Group type: COMPARATOR
Intervention: 5.25% NaOCl
Number of subjects: 48

Group type: COMPARATOR
Intervention: RC‐Prep
Number of subjects: 48

Group type: COMPARATOR
Intervention: Glyde
Number of subjects: 48

Group type: COMPARATOR
Intervention: MTAD
Number of subjects: 48
Study: 19207368

Group type: EXPERIMENTAL
Intervention: Physiotherapeutic intervention applied once a week for 10 sessions
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study: 17279195

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other antiemetics
Number of subjects: 0
Study: 14759109

Group type: EXPERIMENTAL
Intervention: 4.8% tranexamic acid mouthwash over 2 days
Number of subjects: 85

Group type: COMPARATOR
Intervention: 4.8% tranexamic acid mouthwash over 5 days
Number of subjects: 85
Study: 10685239

Group type: EXPERIMENTAL
Intervention: Aquaphor ointment applied twice daily for 2 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard skin care (Control)
Number of subjects: 19
Study: 8596489

Group type: EXPERIMENTAL
Intervention: Trelan G‐75 (1,200 mOsm/L, 225 mL) equivalent to 75 g glucose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 75 g glucose in 225 mL water (33.3% solution)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% NaCl solution or water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 g glucose in 150 mL water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trelan G‐75
Number of subjects: 0
Study: 1755396

Group type: EXPERIMENTAL
Intervention: Aerolin Autohaler
Number of subjects: 51

Group type: COMPARATOR
Intervention: Rotahaler
Number of subjects: 51
Study: 6285622

Group type: EXPERIMENTAL
Intervention: High-dose polychemotherapy (cyclophosphamide, 5-FU, MTX, and Velbe)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No polychemotherapy
Number of subjects: 0
Study: 3155939

Group type: EXPERIMENTAL
Intervention: Inversion devices (two for inversion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: GLR suspension traction
Number of subjects: 20
Study: 29797421

Group type: EXPERIMENTAL
Intervention: Opioid overdose cases (OD)
Number of subjects: 132
Study: 27756289

Group type: EXPERIMENTAL
Intervention: Physical activity measured by Global Physical Activity Questionnaire (GPAQ) and ActiGraph accelerometer; duration: 7 days of accelerometer wear; assessment at 14-18 weeks and 28-33 weeks gestation.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT) conducted at 24-28 weeks gestation.
Number of subjects: 80
Study: 24814051

Group type: EXPERIMENTAL
Intervention: Participants with chronic pain
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Participants without chronic pain
Number of subjects: 653

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 653
Study: 22397890

Group type: EXPERIMENTAL
Intervention: Unilateral left sided rTMS
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Bilateral rTMS
Number of subjects: 67

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 67
Study: 20457669

Group type: COMPARATOR
Intervention: Single IUI (112 patients)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Double IUI (114 patients)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Single IUI in unexplained infertility group (45 patients)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Double IUI in unexplained infertility group (49 patients)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Single IUI in mild male factor group (67 patients)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Double IUI in mild male factor group (65 patients)
Number of subjects: 228
Study: 18588560

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg once daily
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 736

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 736
Study: 15759178

Group type: EXPERIMENTAL
Intervention: Prolene
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: VyproII
Number of subjects: 140
Study: 14733985

Group type: EXPERIMENTAL
Intervention: Degraded image training intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training intervention
Number of subjects: 0
Study: 10710013

Group type: EXPERIMENTAL
Intervention: IT1MIN (continuous test with workload increments each minute)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IT3MIN (discontinuous test with 3 min stages)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IT4MIN (discontinuous test with 4 min stages)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IT5MIN (discontinuous test with 5 min stages)
Number of subjects: 11

Group type: COMPARATOR
Intervention: All tests
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IT1MIN
Number of subjects: 11
Study: 8943993

Group type: EXPERIMENTAL
Intervention: Enriched prenatal intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (nonparticipants and comparison women)
Number of subjects: 0
Study: 1767259

Group type: EXPERIMENTAL
Intervention: Cloxacillin prophylaxis
Number of subjects: 175

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 175
Study: 6963163

Group type: EXPERIMENTAL
Intervention: Miconazole vaginal cream with oral nystatin
Number of subjects: 292

Group type: COMPARATOR
Intervention: Other treatment regimens (not specified)
Number of subjects: 292
Study: 30519793

Group type: EXPERIMENTAL
Intervention: Mantente REAL (MR) curriculum
Number of subjects: 676

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 676
Study: 29547159

Group type: EXPERIMENTAL
Intervention: Pyridoxine (30 mg/kg/day) with oral prednisolone (4 mg/kg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oral prednisolone (4 mg/kg/day) alone
Number of subjects: 62
Study: 27385408

Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) at 33°C
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) at 36°C
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: Adjusted for confounders
Number of subjects: 939
Study: 25607696

Group type: EXPERIMENTAL
Intervention: Non‐ablative 1927nm fractionated thulium laser (Fraxel Dual 1550/1927 Laser System, energy level of 10mJ, coverage of 40% and 4‐6 passes)
Number of subjects: 40
Study: 22985607

Group type: COMPARATOR
Intervention: Phlebotomy (450 mL, every 2 weeks until serum ferritin levels of 20 ng/mL)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-dose hydroxychloroquine (100 mg orally, twice weekly, until at least 1 month after normal plasma levels of porphyrin)
Number of subjects: 48
Study: 19438967

Group type: EXPERIMENTAL
Intervention: DAE + CaP surface (NanoTite)
Number of subjects: 15

Group type: COMPARATOR
Intervention: DAE surface (Osseotite)
Number of subjects: 15
Study: 17922939

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) group treatment
Number of subjects: 238

Group type: COMPARATOR
Intervention: COPD education
Number of subjects: 238
Study: 16135835

Group type: EXPERIMENTAL
Intervention: Amnioinfusion
Number of subjects: 1998

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 1998
Study: 12111513

Group type: EXPERIMENTAL
Intervention: Cefazolin, 1g every 8h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cefozopran, 0.5 g every 8h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Flomoxef, 1g every 8h
Number of subjects: 24
Study: 10332014

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment (24 sessions of 15 minutes, frequency 0.89 MHz, intensity 2.5 W/cm², pulsed mode 1:4)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 63
Study: 8762303

Group type: EXPERIMENTAL
Intervention: Conditioning trials with background stimuli moving at a constant horizontal velocity
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Conditioning stimuli moving to the left (opposite to the direction of eye movement)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Conditioning stimuli moving to the right (same direction as eye movement)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Test trials with 12 deg/sec rightward smooth pursuit
Number of subjects: 8

Group type: COMPARATOR
Intervention: Additional controls
Number of subjects: 8
Study: 1752118

Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6351824

Group type: EXPERIMENTAL
Intervention: Application of a thick firm pad and tight bandage
Number of subjects: 12

Group type: COMPARATOR
Intervention: Other methods (not specified)
Number of subjects: 12
Study: 31758475

Group type: EXPERIMENTAL
Intervention: Increased adherence to Mediterranean diet (MedDiet)
Number of subjects: 78
Study: 29172236

Group type: EXPERIMENTAL
Intervention: Suture repair alone
Number of subjects: 119

Group type: COMPARATOR
Intervention: Proximal diversion or anastomotic reconstruction
Number of subjects: 119
Study: 30634204

Group type: EXPERIMENTAL
Intervention: Rhubarb (80 mg/kg, twice per day) combined with medicinal activated carbon (1.5 g each time, thrice per day) for 8 weeks
Number of subjects: 126

Group type: COMPARATOR
Intervention: Medicinal activated carbon (1.5 g each time, thrice per day) for 8 weeks
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Rhubarb combined with medicinal activated carbon
Number of subjects: 126
Study: 25233867

Group type: EXPERIMENTAL
Intervention: Social support physical activity intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 21841087

Group type: EXPERIMENTAL
Intervention: Hot conditions (maximum temperature of 38°C, minimum temperature of 28°C)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Thermoneutral conditions (TNC)
Number of subjects: 12
Study: 20611050

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Supportive Therapy
Number of subjects: 67
Study: 17884442

Group type: EXPERIMENTAL
Intervention: 375 mg extract of green and black tea per day for 3 months
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 750 mg extract of green and black tea per day for 3 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 15386765

Group type: EXPERIMENTAL
Intervention: 5-year disease-free survivors
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Women with recurrence
Number of subjects: 267

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 267
Study: 12053829

Group type: EXPERIMENTAL
Intervention: Prevention and treatment strategies for traveller's diarrhoea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Investigation of patients with persistent symptoms after returning home
Number of subjects: 0
Study: 9455509

Group type: EXPERIMENTAL
Intervention: Topical paromomycin/MBCL plus injectable Sb for 7 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Topical placebo plus injectable Sb for 7 days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Topical paromomycin/MBCL plus injectable Sb for 3 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Injectable Sb for 20 days
Number of subjects: 150
Study: 7658950

Group type: EXPERIMENTAL
Intervention: Drink with 6% carbohydrates and 0 mmol.l‐1 Na+
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Drink with 6% carbohydrates and 8.8 mmol.l‐1 Na+
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Drink with 6% carbohydrates and 18.5 mmol.l‐1 Na+
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water (neither CHO nor Na+)
Number of subjects: 12
Study: 2663739

Group type: EXPERIMENTAL
Intervention: Functional treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Operative treatment
Number of subjects: 80
Study: 1100361

Group type: EXPERIMENTAL
Intervention: Loxapine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 49
Study: 30117625

Group type: EXPERIMENTAL
Intervention: Nomogram predicting 1-year overall survival
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Nomogram predicting half-year disease-free survival
Number of subjects: 358
Study: 27458234

Group type: EXPERIMENTAL
Intervention: Inhaled sodium nitrite (90 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 24875671

Group type: EXPERIMENTAL
Intervention: High potassium diet
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low potassium diet
Number of subjects: 35
Study: 21978663

Group type: EXPERIMENTAL
Intervention: Painkillers only
Number of subjects: 15272

Group type: EXPERIMENTAL
Intervention: Painkillers with other medications
Number of subjects: 15272

Group type: EXPERIMENTAL
Intervention: Physiotherapy or exercise
Number of subjects: 15272

Group type: EXPERIMENTAL
Intervention: Referral to a specialist
Number of subjects: 15272

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 15272
Study: 20038737

Group type: EXPERIMENTAL
Intervention: Silver-coated endotracheal tube (ETT)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (uncoated ETT)
Number of subjects: 93
Study: 18601851

Group type: EXPERIMENTAL
Intervention: Dishen Qufeng Decoction (DSQFD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cetirizine
Number of subjects: 60
Study: 16794570

Group type: EXPERIMENTAL
Intervention: 50 mg amantadine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 100 mg amantadine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Amantadine (50 mg and 100 mg)
Number of subjects: 14
Study: 14671167

Group type: EXPERIMENTAL
Intervention: Ethanol instillation
Number of subjects: 66

Group type: COMPARATOR
Intervention: Isotonic saline instillation
Number of subjects: 66
Study: 11211584

Group type: EXPERIMENTAL
Intervention: Amnioinfusion
Number of subjects: 0
Study: 8809929

Group type: EXPERIMENTAL
Intervention: Exercise program (twice a week for 8 weeks)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 106
Study: 7941802

Group type: EXPERIMENTAL
Intervention: Intravenous glucose 5% plus electrolytes, neostigmine, and dexpanthenon (Group A)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standardized commercially available solutions without intravenous stimulation of the bowel (Group B)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 76
Study: 3124620

Group type: COMPARATOR
Intervention: Breathing room air
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breathing 2% carbon dioxide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breathing 4% carbon dioxide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Controlled hyperventilation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fetal gross body movements
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fetal heart rate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fetal heart rate variability
Number of subjects: 12
Study: 30961913

Group type: EXPERIMENTAL
Intervention: Recruitment manoeuvres with PEEP titration
Number of subjects: 1010
Study: 28291976

Group type: EXPERIMENTAL
Intervention: Psychoeducation group program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 40
Study: 27789120

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 22907789

Group type: EXPERIMENTAL
Intervention: Sour bolus flavor
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Sweet bolus flavor
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Salty bolus flavor
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control subjects (no bolus flavor)
Number of subjects: 51
Study: 21084654

Group type: EXPERIMENTAL
Intervention: High-fiber rye bread (RB)
Number of subjects: 39

Group type: COMPARATOR
Intervention: White-wheat bread (WB)
Number of subjects: 39
Study: 19054526

Group type: EXPERIMENTAL
Intervention: Fetuses of diabetic mothers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infants of diabetic mothers (IDM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal glycosylated hemoglobin
Number of subjects: 0
Study: 17095972

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EA) with continuous infusion of fentanyl and bupivacaine for 2 days after VATS
Number of subjects: 46

Group type: COMPARATOR
Intervention: No epidural analgesia (NEA)
Number of subjects: 46
Study: 15005472

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using Fuji IX GP and Ketac‐Molar Aplicap in Class II cavities
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cavity preparation using Fuji IX GP and Ketac‐Molar Aplicap in Class II cavities
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using Fuji IX GP and Ketac‐Molar Aplicap in Class I cavities
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cavity preparation using GK-amalgam in Class I cavities
Number of subjects: 60
Study: 11354285

Group type: EXPERIMENTAL
Intervention: Enteric-coated tegafur/uracil
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 56
Study: 8869333

Group type: EXPERIMENTAL
Intervention: Blunt-tipped needle
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cutting needle
Number of subjects: 85
Study: 1671665

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 250 mg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 500 mg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 750 mg/day
Number of subjects: 18
Study: 6143335

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study: 30793924

Group type: EXPERIMENTAL
Intervention: Nephrostomy tube (14F) removed 48 hours after surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ureteral catheter (6F) removed at postoperative 12th hour
Number of subjects: 60
Study: 29617922

Group type: EXPERIMENTAL
Intervention: Azithromycin (single mass distribution)
Number of subjects: 21
Study: 26399865

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IUs thrice weekly for 8 weeks and 50,000 IU every other week for 8 weeks)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 23548455

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 20940005

Group type: EXPERIMENTAL
Intervention: Propofol detected in BAL for group I (induction)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Propofol detected in BAL for group P (PEEP=10 cm H₂O)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Propofol detected in BAL for group Z (PEEP=0 cm H₂O)
Number of subjects: 45
Study: 19586799

Group type: EXPERIMENTAL
Intervention: Simvastatin/Ezetimibe 40/10 mg daily
Number of subjects: 1873

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1873
Study: 17561473

Group type: EXPERIMENTAL
Intervention: OMA orthopedic appliance
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (untreated Class III subjects)
Number of subjects: 20
Study: 15152874

Group type: EXPERIMENTAL
Intervention: Cefditoren twice a day for 10 days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cefuroxim twice a day for 10 days
Number of subjects: 45
Study: 11778092

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: 0.5% ropivacaine
Number of subjects: 45
Study: 9848851

Group type: EXPERIMENTAL
Intervention: N-methyl-D-aspartate receptor antagonist Selfotel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6-month Glasgow Outcome Scale scores
Number of subjects: 0
Study: 8683947

Group type: EXPERIMENTAL
Intervention: Coordinated Approach
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard school health program
Number of subjects: 600
Study: 2486382

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isoproterenol infusion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Anxiety levels measured by panic description scale
Number of subjects: 17
Study: 826945

Group type: EXPERIMENTAL
Intervention: Marijuana (0.7 mg of delta‐9‐tetrahydrocannabinol/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethanol (1.0 ml/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30311692

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation technique (30 min at 20 Hz and 200 cycles/s, once a week for 12 weeks)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Percutaneous therapy (PTNS) (30 min at 20 Hz and 200 cycles/s, once a week for 12 weeks)
Number of subjects: 68
Study: 28846513

Group type: COMPARATOR
Intervention: MICT (Moderate-Intensity Continuous Training) - 30 min at 60%-70% HR peak/session, 150 min/week
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 4HIIT (High-Intensity Interval Training) - 4×4 min bouts at 85%-95% HR peak, interspersed with 3 min active recovery at 50%-70% HR peak, 114 min/week
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 1HIIT (High-Intensity Interval Training) - 1×4 min bout at 85%-95% HR peak, 51 min/week
Number of subjects: 99
Study: 26115420

Group type: EXPERIMENTAL
Intervention: Doming of the diaphragm technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23774331

Group type: EXPERIMENTAL
Intervention: High E/Ea ratio
Number of subjects: 356
Study: 21447261

Group type: EXPERIMENTAL
Intervention: Wrist splint
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cast
Number of subjects: 100
Study: 19756416

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (1500 mg/day) + omega-3 fatty acids (EPA and DHA)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Glucosamine sulfate alone
Number of subjects: 177
Study: 16633145

Group type: EXPERIMENTAL
Intervention: Galantamine hydrogen bromide (HBr) at a mean daily dose of 19.8 mg (± 6.4 mg) for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo at a mean daily dose of 21.8 mg (± 4.6 mg) for 12 weeks
Number of subjects: 36